CD33 and Alzheimer disease: Data from genome-wide association studies (GWASs) on sporadic AD cases showing associations between AD and genes involved in innate immunity (e.g., TREM2, CD33) suggest that inflammation is probably not only a consequence of the accumulation of Aβ and p-tau in the AD brain but may also modulate disease progression [87,88].